Advertisement

#doravirine

Treatment: Merck’s Doravirine

Compared with a regimen based on Prezista, doravirine was better for blood lipids, including cholesterol and triglycerides.

Merck’s Experimental HIV Drug Doravirine Posts Promising 96-Week Results

Compared with a regimen based on Prezista, doravirine was better for blood lipids, including cholesterol and triglycerides.

Merck Applies to FDA for Approval of New HIV Med Doravirine

The new drug application is for doravirine as both an individual tablet and part of a combination tablet.

Doravirine Combo Is Effective and Has Fewer Side Effects Than Atripla

The new single-tablet NNRTI regimen was less likely than Atripla to cause neurological symptoms.

Merck’s Doravirine Treats HIV as Well as Norvir-Boosted Prezista

Used as a part of a multidrug HIV regimen, the investigational doravirine is also better for cholesterol levels than Norvir/Prezista.

Pifeltro

Delstrigo

Advertisement